(Q40522824)

English

Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment

scientific article published on May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment (English)

1 reference

Europe PubMed Central

21 September 2017

0 references

author name string

G L Christensen

1

1 reference

Europe PubMed Central

21 September 2017

J S Jepsen

2

1 reference

Europe PubMed Central

21 September 2017

C K Fog

3

1 reference

Europe PubMed Central

21 September 2017

I J Christensen

4

1 reference

Europe PubMed Central

21 September 2017

A E Lykkesfeldt

5

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

21 September 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

21 September 2017

85

1 reference

Europe PubMed Central

21 September 2017

1

1 reference

Europe PubMed Central

21 September 2017

53-63

1 reference

Europe PubMed Central

21 September 2017

https://scigraph.springernature.com/pub.10.1023/b:brea.0000021047.37869.95

0 references

Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

21 January 2018

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of biologic markers in patient selection and application to disease prevention

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of estrogen and progesterone receptors in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical calcipotriol treatment in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

MCF-7/VD(R): a new vitamin D resistant cell line

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitivity to growth suppression by 1alpha,25-dihydroxyvitamin D(3) among MCF-7 clones correlates with Vitamin D receptor protein induction

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

The statistics of synergism

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000021047.37869.95

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/B:BREA.0000021047.37869.95

1 reference

Europe PubMed Central

21 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40522824&oldid=2107307420"